Target to Patient

We are thrilled to share that we will be showcasing our services at Target to Patient Conference in Hinxton, UK.

Join us at the Wellcome Genome Campus to discover how utilising CETSA® to confirm target engagement of candidate drugs can accelerate your Drug Discovery projects and reduce costs compared to traditional methods.

    • Visit us at Exhibition Booth 3.

    • Meet our team of experts.

    • Review our new Poster.

Poster Presentation

  • Poster Title: Cellular Thermal Shift Assay (CETSA®) Emerges as a Powerful Tool that Enables Target Engagement Assessment in Preclinical and Clinical settings.

     

  • Date: Monday April 29, 2024

     

  • Presentation Time:

      • 12:25 – 13:45, Poster Session and Lunch

      • 18:30 – 19:30, Poster Session and pre-dinner drinks

Poster Abstract

Are you interested in delving deeper into our offerings before the conference? Download our brand new CETSA in Whole Blood Application Note!
Don’t hesitate to contact us if you have any questions or would like to arrange a meeting over coffee or lunch at the conference to discuss how our solutions can accelerate your project.

CETSA in Blood-AppNote_mckp

Speak to our experts

Learn how CETSA® can enable your project by talking to one of our Drug Discovery experts.

Contact Us